General Information
Version
6.5
Revision date
2023-02-11
Product name
Chicoric Acid, United States Pharmacopeia (USP) Reference Standard
CAS No.
6537-80-0
REACH No
is
Emergency telephone
900-868538 (CHEMTREC España
Icons in SDS
Company Information
company name
Merck Life Science S.L
e-mail address of the competent person responsible for the Safety Data Sheet
serviciotecnico@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
H317
May cause an allergic skin reaction
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves. P284 Wear respiratory protection. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
